721 related articles for article (PubMed ID: 16567607)
1. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
O'Malley SS; Cooney JL; Krishnan-Sarin S; Dubin JA; McKee SA; Cooney NL; Blakeslee A; Meandzija B; Romano-Dahlgard D; Wu R; Makuch R; Jatlow P
Arch Intern Med; 2006 Mar; 166(6):667-74. PubMed ID: 16567607
[TBL] [Abstract][Full Text] [Related]
2. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
[TBL] [Abstract][Full Text] [Related]
3. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
[TBL] [Abstract][Full Text] [Related]
5. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers.
Shiffman S; Sweeney CT; Ferguson SG; Sembower MA; Gitchell JG
Clin Ther; 2008 Oct; 30(10):1852-8. PubMed ID: 19014840
[TBL] [Abstract][Full Text] [Related]
6. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
7. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.
Daughton DM; Fortmann SP; Glover ED; Hatsukami DK; Heatley SA; Lichtenstein E; Repsher L; Millatmal T; Killen JD; Nowak RT; Ullrich F; Patil KD; Rennard SI
Prev Med; 1999 Feb; 28(2):113-8. PubMed ID: 10048102
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
Becker KM; Rose JE; Albino AP
Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
[TBL] [Abstract][Full Text] [Related]
10. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
[TBL] [Abstract][Full Text] [Related]
11. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
Jorenby DE; Leischow SJ; Nides MA; Rennard SI; Johnston JA; Hughes AR; Smith SS; Muramoto ML; Daughton DM; Doan K; Fiore MC; Baker TB
N Engl J Med; 1999 Mar; 340(9):685-91. PubMed ID: 10053177
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences.
King A; de Wit H; Riley RC; Cao D; Niaura R; Hatsukami D
Nicotine Tob Res; 2006 Oct; 8(5):671-82. PubMed ID: 17008194
[TBL] [Abstract][Full Text] [Related]
13. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
Yudkin PL; Jones L; Lancaster T; Fowler GH
Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618
[TBL] [Abstract][Full Text] [Related]
14. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
Rose JE; Herskovic JE; Behm FM; Westman EC
Nicotine Tob Res; 2009 Sep; 11(9):1067-75. PubMed ID: 19567826
[TBL] [Abstract][Full Text] [Related]
15. Postintervention effect of nicotine replacement therapy for smoking reduction: a randomized trial with a 5-year follow-up.
Etter JF; Laszlo E
J Clin Psychopharmacol; 2007 Apr; 27(2):151-5. PubMed ID: 17414237
[TBL] [Abstract][Full Text] [Related]
16. Varenicline for smoking cessation: a placebo-controlled, randomized study.
Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
[TBL] [Abstract][Full Text] [Related]
17. An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects.
Wilcox CS; Oskooilar N; Erickson JS; Billes SK; Katz BB; Tollefson G; Dunayevich E
Addict Behav; 2010 Mar; 35(3):229-34. PubMed ID: 19926400
[TBL] [Abstract][Full Text] [Related]
18. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?
Rezaishiraz H; Hyland A; Mahoney MC; O'Connor RJ; Cummings KM
Nicotine Tob Res; 2007 Nov; 9(11):1139-46. PubMed ID: 17978987
[TBL] [Abstract][Full Text] [Related]
19. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial.
Shiffman S; Ferguson SG; Strahs KR
Am J Prev Med; 2009 Feb; 36(2):96-104.e1. PubMed ID: 19135903
[TBL] [Abstract][Full Text] [Related]
20. Nicotine patch and paroxetine for smoking cessation.
Killen JD; Fortmann SP; Schatzberg AF; Hayward C; Sussman L; Rothman M; Strausberg L; Varady A
J Consult Clin Psychol; 2000 Oct; 68(5):883-9. PubMed ID: 11068974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
